Unitary pharmaceutical dosage form

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8598185
APP PUB NO 20070099902A1
SERIAL NO

11453122

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GILEAD SCIENCES LLC333 LAKESIDE DRIVE FOSTER CITY CA 94404

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dahl, Terrence C Sunnyvale, US 25 383
Hussain, Munir A Belle Mead, US 14 315
Jerzewski, Robert L Belle Mead, US 7 156
Lipper, Robert A Pennington, US 10 92
Menning, Mark M San Francisco, US 21 265
Oliyai, Reza San Carlos, US 45 890
Yang, Taiyin Saratoga, US 7 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00